首页 | 本学科首页   官方微博 | 高级检索  
     


Reply to "Insufficient evidence that agitation is common in gamma-hydroxybutyrate (GHB) toxicity," submitted in response to our original article entitled, "Agitation is common in gamma-hydroxybutyrate toxicity," published in AJEM, May 2005
Authors:Zvosec Deborah L  Smith Stephen W
Affiliation:1. Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599;2. Department of Pharmacy, National University of Singapore, Singapore 117543;3. Department of Pharmacology, National University Health System, Singapore 117597;4. Department of Haematology-Oncology, National University Health System, Singapore 119228;1. Department of Urology, The Fifth People''s Hospital of Shanghai, Urology Research Center, Fudan University, Shanghai 200240, China;2. Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, No. 44 West Wenhua Road, Jinan, Shandong 250012, China;1. Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;2. Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands;3. Translational Cancer Research Unit, Oncology Center, GZA Hospitals Sint-Augustinus and Department of Oncology, University of Antwerp, Antwerp, Belgium;4. Department of Internal Medicine, Sint Franciscus Gasthuis, Rotterdam, The Netherlands;5. Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands;6. Department of Internal Medicine, IJsselland Hospital, Capelle aan den IJssel, The Netherlands
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号